David A. Siegel Beyond Spring Inc. Transaction History

Two Sigma Advisers, LP

  • $41.3 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$1.13 - $2.66 $33,900 - $79,800
-30,000 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$1.68 - $5.01 $1,512 - $4,509
-900 Reduced 2.91%
30,000 $66,000
Q4 2021

Feb 14, 2022
BUY
$4.02 - $16.84 $124,217 - $520,356
30,900 New
30,900 $140,000
Q2 2021

Aug 16, 2021
SELL
$9.37 - $12.12 $269,856 - $349,056
-28,800 Closed
0 $0
Q1 2021

May 17, 2021
BUY
$10.61 - $15.77 $305,568 - $454,176
28,800 New
28,800 $319,000

Others Institutions Holding BYSI

# of Institutions
21
Shares Held
5.55M
Call Options Held
26K
Put Options Held
2.4K
View Full List

About BeyondSpring Inc.

BYSI Quotes by TradingView
  • Ticker BYSI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,928,900
  • Market Cap $66.6M
  • Description
  • BeyondSpring Inc., a clinical stage biopharmaceutical company, together with its subsidiaries, focuses on the development of cancer therapies. The company's lead asset is the Plinabulin, a selective immune-modulating microtubule-binding agent that has completed Phase III clinical trials for the prevention of chemotherapy-induced neutropenia; and...
More about BYSI
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email